AU7057700A - Compounds which modulate the activity of an lpa receptor - Google Patents

Compounds which modulate the activity of an lpa receptor

Info

Publication number
AU7057700A
AU7057700A AU70577/00A AU7057700A AU7057700A AU 7057700 A AU7057700 A AU 7057700A AU 70577/00 A AU70577/00 A AU 70577/00A AU 7057700 A AU7057700 A AU 7057700A AU 7057700 A AU7057700 A AU 7057700A
Authority
AU
Australia
Prior art keywords
modulate
activity
compounds
lpa receptor
lpa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70577/00A
Inventor
James Erickson
J. Graham Goddard
Michael Kiefer
Donald Picker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atairgin Technologies Inc
Original Assignee
Atairgin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atairgin Technologies Inc filed Critical Atairgin Technologies Inc
Publication of AU7057700A publication Critical patent/AU7057700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU70577/00A 1999-08-18 2000-08-11 Compounds which modulate the activity of an lpa receptor Abandoned AU7057700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37639999A 1999-08-18 1999-08-18
US09376399 1999-08-18
PCT/US2000/022101 WO2001012838A2 (en) 1999-08-18 2000-08-11 Compounds which modulate the activity of an lpa receptor

Publications (1)

Publication Number Publication Date
AU7057700A true AU7057700A (en) 2001-03-13

Family

ID=23484875

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70577/00A Abandoned AU7057700A (en) 1999-08-18 2000-08-11 Compounds which modulate the activity of an lpa receptor

Country Status (2)

Country Link
AU (1) AU7057700A (en)
WO (1) WO2001012838A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4836345B2 (en) * 2001-04-13 2011-12-14 きみ子 室伏 Neuronal survival promoter containing cyclic phosphatidic acid derivative
AU2003278165A1 (en) * 2002-11-13 2004-06-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2)
JP5826742B2 (en) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド Pharmaceutical composition for preventing or treating nerve damage and disease
US8975235B2 (en) 2011-03-20 2015-03-10 Intermune, Inc. Lysophosphatidic acid receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176423A (en) * 1974-12-26 1976-07-02 Kao Corp HIIRYOYOKOKINZAI
US5565439A (en) * 1992-11-24 1996-10-15 The Procter & Gamble Company Methods of using lysophosphatidic acid for treating hyperproliferative conditions
US5480877A (en) * 1993-11-02 1996-01-02 Wisconsin Alumni Research Foundation Use of lysophosphatidic acids to enhance fibronectin binding
FR2734158B1 (en) * 1995-05-17 1997-06-27 Roche Posay Lab Pharma COMBINATION OF A COMPOUND WITH ANTI-MICROBIAL ACTIVITY AND A MONOALKYLETHER OF GLYCEROL
AU751876B2 (en) * 1997-03-19 2002-08-29 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
CA2301921A1 (en) * 1997-08-20 1999-02-25 John Graham Goddard Compositions containing polyethylene glycol and uses thereof
WO1999019513A2 (en) * 1997-10-10 1999-04-22 Lxr Biotechnology, Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
WO1999047101A2 (en) * 1998-03-18 1999-09-23 Lxr Biotechnology, Inc. Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof

Also Published As

Publication number Publication date
WO2001012838A2 (en) 2001-02-22
WO2001012838A3 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU9794598A (en) Methods for detecting compounds which modulate the activity of an lpa receptor
AU7582298A (en) Tissue specific prodrug
AU6292199A (en) Flex sole
AU5546000A (en) Compounds
AU4551599A (en) Novel therapeutic agents that modulate endothelin receptors
AU1129600A (en) Multi-functional coatings for medical devices
AU3474200A (en) X-ray interferometer
AU5611800A (en) Image generating system
AU2613301A (en) Fluidized fillshoe system
AU4425399A (en) Novel therapeutic agents that modulate 5-ht receptors
AU1746401A (en) Compounds
AU3997700A (en) Anti-first-pass effect compounds
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
AU5719500A (en) Applicator assembly
AU1682601A (en) Toner assembly
AU5787201A (en) Compounds active at the glucocorticoid receptor
AU7057700A (en) Compounds which modulate the activity of an lpa receptor
AU1786799A (en) Composition for the controlled release of active compounds
AU2783099A (en) Receptor derived peptides as modulators of receptor activity
AU8532798A (en) Compounds which delay the release of active substances
AU2356301A (en) Silylated heterocyclic compounds
AU8602198A (en) Synaptojanin isoform
AU6550800A (en) Hepoxilin analogs
AU5276300A (en) Taccalonolide microtubule stabilizing agents
AU4755200A (en) Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase